Aurinia Pharmaceuticals Inc (AUPH)

[Jesspro]

RMB, both parties play to win. The seller has an upper hand because their product is already a sure winner with no competition in sight for the next 5/8 years. There are multiple suitors rumored. They have a patent whose expiration the buyers can consider eternity. They have a very solid and a very long runway. They A2 data is way beyond compare, a solid 3 year stellar data. The trial data p-values is very very hard to overcome by any upcoming competitions. So, relax and enjoy the drama…jmho.